Zydus gets 180 days’ shared exclusivity for Roflumilast tablets
Zydus’ Roflumilast tablets are indicated as a treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD)…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.